14-50908981-TA-TAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_002863.5(PYGL):c.2178-27dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 1,531,846 control chromosomes in the GnomAD database, including 72,991 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.35 ( 10267 hom., cov: 0)
Exomes 𝑓: 0.28 ( 62724 hom. )
Consequence
PYGL
NM_002863.5 intron
NM_002863.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.780
Publications
5 publications found
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
- glycogen storage disease VIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 14-50908981-T-TA is Benign according to our data. Variant chr14-50908981-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PYGL | ENST00000216392.8 | c.2178-27_2178-26insT | intron_variant | Intron 17 of 19 | 1 | NM_002863.5 | ENSP00000216392.7 | |||
| PYGL | ENST00000532462.5 | c.2178-27_2178-26insT | intron_variant | Intron 17 of 19 | 1 | ENSP00000431657.1 | ||||
| PYGL | ENST00000544180.6 | c.2076-27_2076-26insT | intron_variant | Intron 16 of 18 | 2 | ENSP00000443787.1 | ||||
| PYGL | ENST00000532107.2 | n.351-27_351-26insT | intron_variant | Intron 2 of 3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.352 AC: 53206AN: 151026Hom.: 10238 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
53206
AN:
151026
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.356 AC: 88857AN: 249322 AF XY: 0.344 show subpopulations
GnomAD2 exomes
AF:
AC:
88857
AN:
249322
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.284 AC: 392300AN: 1380708Hom.: 62724 Cov.: 33 AF XY: 0.285 AC XY: 196783AN XY: 690496 show subpopulations
GnomAD4 exome
AF:
AC:
392300
AN:
1380708
Hom.:
Cov.:
33
AF XY:
AC XY:
196783
AN XY:
690496
show subpopulations
African (AFR)
AF:
AC:
13782
AN:
30900
American (AMR)
AF:
AC:
24327
AN:
43958
Ashkenazi Jewish (ASJ)
AF:
AC:
6171
AN:
25398
East Asian (EAS)
AF:
AC:
20909
AN:
37930
South Asian (SAS)
AF:
AC:
27986
AN:
84318
European-Finnish (FIN)
AF:
AC:
14163
AN:
51348
Middle Eastern (MID)
AF:
AC:
2070
AN:
5594
European-Non Finnish (NFE)
AF:
AC:
265333
AN:
1044242
Other (OTH)
AF:
AC:
17559
AN:
57020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
11897
23795
35692
47590
59487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8874
17748
26622
35496
44370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.353 AC: 53277AN: 151138Hom.: 10267 Cov.: 0 AF XY: 0.357 AC XY: 26338AN XY: 73864 show subpopulations
GnomAD4 genome
AF:
AC:
53277
AN:
151138
Hom.:
Cov.:
0
AF XY:
AC XY:
26338
AN XY:
73864
show subpopulations
African (AFR)
AF:
AC:
18595
AN:
41050
American (AMR)
AF:
AC:
6813
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
AC:
841
AN:
3466
East Asian (EAS)
AF:
AC:
2833
AN:
5106
South Asian (SAS)
AF:
AC:
1658
AN:
4774
European-Finnish (FIN)
AF:
AC:
3000
AN:
10368
Middle Eastern (MID)
AF:
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18544
AN:
67868
Other (OTH)
AF:
AC:
761
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1570
3140
4710
6280
7850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 13, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
BranchPoint Hunter
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.